Marizyme Inc (MRZM)
0.072
-0.02
(-24.21%)
USD |
OTCM |
May 03, 16:00
Marizyme Gross Profit Margin (Quarterly): 71.91% for Sept. 30, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 71.91% |
| June 30, 2023 | 73.15% |
| March 31, 2023 | 69.55% |
| December 31, 2022 | 70.95% |
| September 30, 2022 | 79.60% |
| June 30, 2022 | 82.16% |
| March 31, 2022 | |
| December 31, 2021 | -42.79% |
| September 30, 2021 | 50.68% |
| June 30, 2021 | 25.85% |
| March 31, 2021 | |
| December 31, 2020 | 54.85% |
| September 30, 2020 | 79.43% |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 99.97% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | -14.27% |
| March 31, 2018 | |
| December 31, 2017 | -78.05% |
| September 30, 2017 | 46.36% |
| Date | Value |
|---|---|
| December 31, 2013 | 50.74% |
| September 30, 2013 | 55.13% |
| June 30, 2013 | 56.50% |
| March 31, 2013 | 40.63% |
| December 31, 2012 | 44.17% |
| September 30, 2012 | 43.73% |
| June 30, 2012 | 38.94% |
| March 31, 2012 | 32.18% |
| December 31, 2011 | 42.96% |
| September 30, 2011 | 51.98% |
| June 30, 2011 | 54.38% |
| March 31, 2011 | 44.66% |
| December 31, 2010 | 49.30% |
| September 30, 2010 | 47.32% |
| June 30, 2010 | 56.78% |
| March 31, 2010 | 64.24% |
| December 31, 2009 | |
| September 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | |
| December 31, 2008 | 63.26% |
| September 30, 2008 | -17.97% |
| June 30, 2008 | 70.41% |
| March 31, 2008 | -37.69% |
| December 31, 2007 | 56.33% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-42.79%
Minimum
Dec 2021
82.16%
Maximum
Jun 2022
55.94%
Average
70.95%
Median
Dec 2022
Gross Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -671.6% |
| Return on Assets | -184.4% |
| Return on Invested Capital | -378.5% |
| Profit Margin (Quarterly) | -17.88K% |
| Operating Margin (Quarterly) | -2.68K% |
| Return on Net Operating Assets | -185.6% |